Enregistrement :
29
de
41
(2016-04-05
à
2016-10-03)
Politique ou Programme
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Policy or program: National pharmacare with respect to the coordinaton of drug plan policies and programs
Research and Development Legislative Proposal, Policy or Program, with respect to the strategy on innovation.
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Politique ou Programme, Proposition législative, Projet de loi ou résolution
Comprehensive Economic and Trade Agreement Negotiations as it relates to the protection of intellectual property rights.
Politique ou Programme, Règlement
Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
Proposition législative, Projet de loi ou résolution
Patent Act as it relates to the regulation of intellectual property for therapeutic products
Proposition législative, Projet de loi ou résolution, Règlement
Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products
Règlement
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.